Macitentan D4

Names

[ Name ]:
Macitentan D4

[Synonym ]:
N-[5-(4-Bromophenyl)-6-({2-[(5-bromo-2-pyrimidinyl)oxy](H)ethyl}oxy)-4-pyrimidinyl]-N'-propylsulfuric diamide
Sulfamide, N-[5-(4-bromophenyl)-6-[[2-[(5-bromo-2-pyrimidinyl)oxy]ethyl-1,1,2,2-d]oxy]-4-pyrimidinyl]-N'-propyl-

Biological Activity

[Description]:

Macitentan D4 (ACT-064992 D4) is a deuterium labeled Sulfamethoxazole. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin) receptor antagonist. Macitentan is used for the potential treatment of idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH)[1].

[Related Catalog]:

Signaling Pathways >> Apoptosis >> Apoptosis

Research Areas >> Cardiovascular Disease

Signaling Pathways >> GPCR/G Protein >> Endothelin Receptor

[Target]

ETA/ETB[1]

[References]

[1]. Corallo C, et al. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. Arthritis Res Ther. 2016 Oct 6;18(1):228.

Chemical & Physical Properties

[ Density]:
1.7±0.1 g/cm3

[ Boiling Point ]:
692.4±65.0 °C at 760 mmHg

[ Molecular Formula ]:
C₁₉H₁₆D₄Br₂N₆O₄S

[ Molecular Weight ]:
592.29800

[ Flash Point ]:
372.5±34.3 °C

[ Exact Mass ]:
589.98800

[ PSA ]:
136.60000

[ LogP ]:
5.41

[ Vapour Pressure ]:
0.0±2.2 mmHg at 25°C

[ Index of Refraction ]:
1.634

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.